Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
10/2014
10/30/2014US20140323475 Ep1 receptor ligands
10/30/2014US20140322713 Polymethine compounds and their use as fluorescent labels
10/28/2014US8872422 Dinaphthyl ethylene derivativce, process for preparing it, film prepared from it, and OLED including the film
10/28/2014US8871975 Process for the synthesis of agomelatine
10/28/2014US8871948 (Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
10/28/2014US8871932 Process for the preparation of tadalafil
10/28/2014US8871904 Processes and intermediates
10/28/2014US8871784 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
10/28/2014US8871430 Photoactive compound and photosensitive resin composition comprising the same
10/28/2014US8871429 Fluorine-free fused ring heteroaromatic photoacid generators and resist compositions containing the same
10/23/2014US20140316145 Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases
10/23/2014US20140315965 Bis-(aryl/heteroaryl)-methylene compounds, pharmaceutical compositions containing same and their use for treating cancer
10/23/2014US20140315956 Small molecule inhibitors of il-6 and uses thereof
10/23/2014US20140315889 Hydroxamate derivatives for hdac inhibitor, and the pharmaceutical composition comprising thereof
10/23/2014US20140314685 Ion channel modulating compounds and uses thereof
10/23/2014US20140311890 Photoacid compounds, and related compositions, methods and systems
10/21/2014US8865933 Method for obtaining optically pure amino acids
10/21/2014US8865918 Androgen receptor modulator compounds and methods
10/21/2014US8865916 Functionalized diamond nanoparticles
10/21/2014US8865915 Process for the preparation of the L-arginine salt of perindopril
10/21/2014US8865914 Fluorescent probes for detection of copper
10/21/2014US8865903 Continuous process for the alkylation of cyclic tertiary amines
10/21/2014US8865702 B1-antagonists
10/21/2014US8865701 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer'S disease
10/21/2014US8865323 Biscarbazole derivative, material for organic electroluminescence device and organic electroluminescence device using the same
10/21/2014US8865322 Dendrimer and organic light-emitting device using the same
10/21/2014US8865130 Methods and compositions for diagnostic and therapeutic targeting of COX-2
10/16/2014US20140309436 Thalidomide analogs
10/16/2014US20140309435 Process for preparing esters from formates and olefinically unsaturated compounds
10/16/2014US20140309434 Synthesis of psuedo indoxyl derivatives
10/16/2014US20140309272 Bis-indolic derivatives, a process for preparing the same and their uses as a drug
10/16/2014US20140309190 Bicyclic aryl sphingosine 1-phosphate analogs
10/16/2014US20140308317 Polymeric Compounds And Methods Of Making And Using The Same
10/14/2014US8859814 Alpha-substituted N-sulfonyl gylcine amides antagonists of CCR10, compositions containing the same and methods for using them
10/14/2014US8859802 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
10/14/2014US8859798 Isothiocyanate compounds, pharmaceutical compositions, and uses thereof
10/14/2014US8859784 Stereomerically pure fused bicyclic proline compounds useful for preparing hepatitis C protease inhibitors
10/14/2014US8859783 Indirubin-3′-oxime derivatives as potent cyclin dependent kinase inhibitors
10/14/2014US8859782 Process for the preparation of 1-H-pyrrolidine-2,4-dione derivatives
10/14/2014US8859620 Phthalanilate compounds and methods of use
10/14/2014US8859608 Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction
10/14/2014US8859599 Androgen receptor modulating compounds, preparation and uses thereof
10/14/2014US8859111 Materials for organic electroluminescent devices
10/14/2014US8859109 Compound for organic electroluminescent device and organic electroluminescent device using the same
10/09/2014WO2014164222A1 Compounds for the treatment of neurological disorders
10/09/2014WO2014163305A1 Compound for organic electronic element, organic electronic element using same, and electronic device thereof
10/09/2014WO2014163228A1 Novel organic electroluminescent element compound and organic electroluminescent element comprising same
10/09/2014WO2014161888A1 N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
10/09/2014US20140303382 Process for the preparation of 6-chloro-2,3,4,9-tetrahydro-1h-carbazole-1-carboxamide and intermediates thereof
10/09/2014US20140303328 Cross-linker
10/09/2014US20140303224 Carbazole compounds and therapeutic uses of the compounds
10/09/2014US20140303186 Nitrogen-containing fused ring compounds as crth2 antagonists
10/09/2014US20140303138 Substituted oxindole-derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
10/09/2014US20140301976 Novel hydroxamates as therapeutic agents
10/08/2014EP2786985A2 Antagonists of the glucagon receptor
10/08/2014EP2786983A1 Compounds for use in a photoelectric conversion material, and intermediates for the preparation thereof
10/07/2014US8853429 Process and intermediate compounds useful in the preparation of statins
10/07/2014US8853420 Compounds
10/07/2014US8853419 Processes for the preparation of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
10/07/2014US8853254 Modulators of ATP-binding cassette transporters
10/07/2014US8853249 Method for producing intermediates for the production of macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereof
10/07/2014US8853215 Derivatives of N-acyl-N′-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
10/07/2014US8853209 1-oxyalkyl-2-carboxy-7-nonsubstituted indole derivatives
10/07/2014US8853175 Phenethylsulfone isoindoline derivatives and their use
10/07/2014US8852758 Aromatic amine compound, and light-emitting element, light-emitting device, and electronic device using the aromatic amine compound
10/07/2014US8852756 Materials for organic electroluminescent devices
10/07/2014US8852599 Immunoconjugates, compositions for making them, and methods of making and use
10/07/2014US8852553 N-alkoxyamide conjugates as imaging agents
10/02/2014WO2014160686A1 Solid forms comprising 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and a coformer, compositions and methods of use thereof
10/02/2014WO2014160586A1 Cyclic n-acyl o-amino phenol cbi derivative
10/02/2014WO2014158209A1 Cyclic peroxide oxidation of aromatic compound production and use thereof
10/02/2014WO2014157574A1 Condensed fluoranthene compound, material for organic electroluminescent element using this compound, organic electroluminescent element using this material, and electronic device
10/02/2014WO2014157565A1 Photoresponsive nucleotide analogue having photocrosslinking ability
10/02/2014WO2014154925A1 Neurogenic compounds comprising melatonin and the efficacy thereof in in vivo experiments for use in the treatment of diseases of the nervous system
10/02/2014US20140296524 Halogenated compounds for photodynamic therapy
10/02/2014US20140296292 Methods and compositions associated with the granulocyte colony-stimulating factor receptor
10/02/2014US20140296278 5-nonyloxytryptamine and related intracellular ph acidifiers for the treatment and prevention of cancer
10/02/2014US20140296249 4-phenylpiperazine derivatives with functionalized linkers as dopamine d3 receptor selective ligands and methods of use
10/02/2014US20140296217 Medicaments for the treatment or prevention of fibrotic diseases
10/02/2014US20140296212 Substituted phenoxypropylcycloamine derivatives as histamine-3 (h3) receptor ligands
10/02/2014US20140295437 Cyanine compounds and their application as quenching compounds
10/02/2014US20140294796 Aromatic-cationic peptides and uses of same
10/02/2014US20140294767 Method of treating hcv infection with a small molecule chk2 inhibitor
10/02/2014US20140294763 Peptidomimetic protease inhibitors
09/2014
09/30/2014US8846952 Detection or quantification of desirable target molecules, novel dyes, composite dyes, and oligonucleotides or polynucleotides comprising such dyes
09/30/2014US8846928 Benzamides and nicotinamides as Syk modulators
09/30/2014US8846910 Matrix metalloproteinase inhibitors
09/30/2014US8846876 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
09/30/2014US8846748 Indolyl or indolinyl hydroxamate compounds
09/30/2014US8846747 Compounds and methods for altering lifespan of eukaryotic organisms
09/30/2014US8846738 Fungicide active substance combinations
09/30/2014US8846674 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
09/30/2014US8846552 Soluble terminally modified imide oligomer using 2-phenyl-4, 4′-diaminodiphenyl ether, varnish, cured product thereof, imide prepreg thereof, and fiber-reinforced laminate having excellent heat resistance
09/30/2014US8846215 Organic light-emitting diode and method for manufacturing same
09/30/2014US8846213 Organic light-emitting device
09/25/2014WO2014153203A2 Alkyl-amine harmine derivatives for promoting bone growth
09/25/2014WO2014153043A1 Compounds and methods for treating cancers
09/25/2014WO2014148591A1 Production method for 1, 2-diol compound
09/25/2014WO2014148493A1 Light-emitting device
09/25/2014WO2014146752A1 Materials for electronic devices
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 458